Research is being conducted on the role of certain molecules in suppressing prostate cancer bone metastasis. These molecules, known as Siglec-engaging immunosuppressive sialoglycans, may interact with immune cells to prevent them from killing cancer cells. The specific mechanisms and pathways involved, including the potential role of related molecules in other types of cancer, are being explored.